Researchers from Taipei Medical University Detail Research in COVID-19 [Validation of Viral Inactivation Protocols for Therapeutic Blood Products against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-COV-2)]

Prensa/medios de comunicación: Research

Períodonov. 29 2022

Cobertura de los medios

1

Cobertura de los medios

  • NombreResearchers from Taipei Medical University Detail Research in COVID-19 [Validation of Viral Inactivation Protocols for Therapeutic Blood Products against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-COV-2)]
    Nombre/canal del medio de comunicaciónNewsRx COVID-19 Daily
    País/TerritorioUnited States
    Fecha11/29/22
    PersonasChing Hsuan Liu